when was tirzepatide approved for weight loss Tirzepatide for Medical Weight Loss

Limited data exists on this approach, but it may offer a middle ground between continuous treatment and complete discontinuation

Published literature describes investigations into pathways such as angiogenesis, the nitric oxide (NO) system, and tissue repair signaling in rodent models (Sikiric et al., 2025, Pharmaceuticals)

After youve been approved for this treatment, youll start your series of injections

The single-dose vials are currently available in the following strengths: 2.5 mg/0.5 mL 5 mg/0.5 mL 7.5 mg/0.5 mL 10 mg/0.5 mL 12.5 mg/0.5 mL 15 mg/0.5 mL Zepbound dosage schedule Typically, healthcare providers recommend starting at the lowest 2.5 mg dose of Zepbound